The Alaris infusion system [Image courtesy of BD] BD (NYSE:BDX) announced a voluntary recall related to certain Alaris and Alaris infusion pump modules. Affected Alaris products may have been serviced ...
BD sent a letter to Alaris pump module users on Oct. 17. The company told customers to immediately remove from use any devices they drop or severely jar. Before reusing a pump, healthcare ...
BD’s Alaris infusion pump and vital signs monitoring system is designed to deliver controlled amounts of fluid, medication, blood and blood products. [Photo courtesy of BD] A federal judge in New ...
The BD Alaris™ Infusion System features a centralised user interface for up to four modules for all major infusion types. The BD Alaris™ Infusion System operates as a single comprehensive system with ...
The company will fix or replace older devices still in use at hospitals as it ramps up to resume sales in its market-leading infusion business. After a string of recalls involving Alaris hardware and ...
Becton, Dickinson and Company’s BDX, or popularly known as BD, initiated the recall of its infusion pumps last month after customer reports indicated software issues, potentially leading to inaccurate ...
ISSUE: CareFusion is recalling the Alaris Pump model 8100, version 9.1.18, because the pump may have a software failure where the pump module will not properly delay an infusion when the Delay Until ...
BD (NYSE: BDX) + is dealing with another recall related to its Alaris infusion pump system. Our sister site, Drug Delivery Business News, reports that the medtech giant announced a voluntary recall ...
FRANKLIN LAKES, N.J., July 18, 2019 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback